Thursday 10 November 2011

GlaxoSmithKline to settle drug disputes for $3bn

GlaxoSmithKline is set to pay one of the pharmaceutical industry’s largest ever fines after resolving disputes with the US government over the way it marketed and developed its drugs, at a cost of $3bn (£1.8bn).

http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8866885/GlaxoSmithKline-to-settle-drug-disputes-for-3bn.html

No comments:

Post a Comment

The lowcarb team value your comments. Thank you for taking the time to contribute to our blog. Please note! negative comments and insults from anonymous idiots, with nothing to add to the debate will not be authorised. However, we welcome constructive criticism.

The best of health to you and yours.

Eddie